Prevalence of metabolic syndrome in 25—45-year-old Novosibirsk dwellers


Cite item

Full Text

Abstract

Aim. To study the prevalence of metabolic syndrome (MS) and its components in a 25—45-year-old Novosibirsk population. Subjects and methods. The Novosibirsk Research Institute of Internal and Preventive Medicine conducted a cross-sectional population-based survey in one of the typical districts of Novosibirsk in 2013—2015. The survey covered 346 men and 408 women. The criteria of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (NCEP-ATP III, 2001), the International Diabetes Federation (IDF, 2005), the Joint Interim Statement (JIS, 2009), and the All-Russian Research Society of Cardiologists (ARRSC, 2009) were used to detect MS. According to the ARRSC criteria, MS was recorded if a waist circumference (WC) was >80 cm for women and >94 cm for men in conjunction with 2 of the following criteria: a blood pressure ≥130/85 mm Hg, triglycerides (TG) ≥1.7 mmol/l, high-density lipoprotein (HDL) cholesterol <1.0 mmol/l for men and <1.2 mmol/l for women, low-density lipoprotein (LDL) cholesterol >3.0 mmol/l, and plasma glucose level ≥6.1 mmol/l. Results. According to the 2009 ARRSC criteria, the prevalence of abdominal obesity, hypertension, hypertriglyceridemia, HDL hypocholestrolemia, LDL hypercholesterolemia, and high plasma glucose level was 42.6, 33.5, 17.5, 24.3, 64.8, and 29%, respectively. The prevalence of MS in 25—45-year-old Novosibirsk people was 17% (19.9% in men and 14.5% in women) according to the 2001 NCEP-ATP III, 27% (29.5% in men and 24.5% in women) according to the 2005 IDF criteria, 30% (35.8% in men and 25% in women) according to the 2009 JIS criteria, and 29.3% (33.2% in men and 26% in women) according to the 2009 ARRSC criteria, this was higher among men than women. There was an increase in the prevalence of MS with age. Conclusion. The highest prevalence of MS was 30 and 29.3% when using the 2009 JIS and the 2009 ARRSC criteria, respectively. Whatever the criterion was used, MS was more frequently recorded in men than women,

References

  1. James PT, Rigby N, Leach R. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prevent Rehabil. 2004;11(1):3-8. doi: 10.1097/01.hjr.0000114707.27531.48
  2. Jorgensen M, Borch-Johnsen K. The metabolic syndrome-is one global definition possible? Diab Med. 2004;21(10):1064-1065. doi: 10.1111/j.1464-5491.2004.01400.x
  3. Ford E. Prevalence of the Metabolic Syndrome Defined by the International Diabetes Federation Among Adults in the U.S. Diabetes Care. 2005;28(11):2745-2749. doi: 10.2337/diacare.28.11.2745
  4. Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl A. Age specific prevalence of the metabolic syndrome by International Diabetes Federation and National Education Program: The Norwegian HUNT 2 study. BMC Public Health. 2007;7(1):220. doi: 10.1186/1471-2458-7-220
  5. Воевода М.И., РагиноЮ.И., ЧернявскийА.М., ЦымбалС.Ю., СемаеваЕ.В., ПолонскаяЯ.В., ИвановаМ.В.Высокая распространенность метаболического синдрома у мужчин с коронарным атеросклерозом в Сибири. Российский кардиологический журнал. 2010;1(81):65-69.
  6. Tunstall-Pedoe H. MONICA, monograph and multimedia sourcebook. Geneva: World Health Organization; 2003:237. doi: 10.1258/jrsm.96.12.613
  7. Ryden L, Standl E, Bartnik M, Berghe GVd, Betteridge J, M de Boer, Cosentino F, Jonsson B, Laakso V, Malmberg R, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I. Guidelines on diabetes, pre-diabetes,and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007;28(1):88-136. doi: 10.1093/eurheartj/ehl261
  8. Pasternak R. National Cholesterol Education Program (NCEP) Guidelines on the Detection, Evaluation and Treatment of Elevated Cholesterol in Adults: Adult Treatment Panel III (ATP III). ACC Cur J Rev. 2002;11(4):37-45. doi: 10.1016/s1062-1458(02)00670-0
  9. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diab Med. 2006;23(5):469-480. doi: 10.1111/j.1464-5491.2006.01858.x
  10. Alberti KG, Eckel RH, Grundy SM, Zimmet P, Cleeman J, Donato K, Fruchart J, James W, Loria C, Smith S. Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-1645. doi: 10.1161/circulationaha.109.192644
  11. Рекомендации экспертов всероссийского научного общества кардиологов по диагностике и лечению метаболического синдрома. Второй пересмотр. Практическая медицина. 2010;5(44):81-101.
  12. Ford ES, Giles WН, Dietz WH. Prevalence of the Metabolic Syndrome Among US Adults: Findings From the Third National Health and Nutrition Examination Survey. Obstet Gynecol Survey. 2002;57(9):576-577. doi: 10.1097/00006254-200209000-00017
  13. Никитин Ю.П., Казека Г.Р., Симонова Г.И. Распространенность компонентов метаболического синдрома X в неорганизованной городской популяции (эпидемиологическое исследование). Кардиология. 2001;9(41):37-40
  14. Симонова Г.И., Мустафина С.В., Печенкина Е.А. Распространенность метаболического синдрома в Сибири: популяционное исследование в г. Новосибирске. Бюллетень Сибирского отделения Российской академии медицинских наук. 2011;5(31):100-106.
  15. Erina A, Libis R, Isaeva E, Savshin D, Rotar O, Solntsev V, Zagranichnaya S, Konradi A, Shlyakhto E. Prevalence of metabolic syndrome in cities of Russian Federation. J Hypertens. 2011;29:е155. doi: 10.1097/00004872-201106001-00391
  16. Mattsson N, Rönnemaa T, Juonala M, Viikari J, Raitakari O. The prevalence of the metabolic syndrome in young adults. The Cardiovascular Risk in Young Finns Study. J Intern Med. 2007;261(2):159-169. doi: 10.1111/j.1365 2796.2006.01752.x
  17. Mancia G, Bombelli M, Corrao G, Facchetti R, Madotto F, Giannattasio C, Trevano F, Grassi G, Zanchetti A, Sega R. Metabolic Syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) Study: Daily Life Blood Pressure, Cardiac Damage, and Prognosis. Hypertension. 2006; 9(1):40-47. doi: 10.1161/01.hyp.0000251933.22091.24
  18. Empana JP, Jouver X. Metabolic syndrome and risk of sudden cardiac death in asymptomatic subjects. Mets Insights. 2006;9:11-15.
  19. Шишкин С.В., Мустафина С.В., Щербакова Л.В., Симонова Г.И. Метаболический синдром и риск инсульта в популяции г. Новосибирска. Кардиоваскулярная терапия и профилактика. 2014;13(3):53-57.
  20. Maharlouei N, Bellissimo N, Ahmadi S, Lankarani, K. Prevalence of metabolic syndrome in pre- and postmenopausal Iranian women. Climacteric. 2012;16(5):561-567. doi: 10.3109/13697137.2012.727504
  21. Sidorenkov O, Nilssen O, Brenn T, Martiushov S, Arkhipovsky V, Grjibovski A. Prevalence of the metabolic syndrome and its components in Northwest Russia: the Arkhangelsk study. BMC Public Health. 2010;10(1):23. doi: 10.1186/1471-2458-10-23
  22. Малютина С.К. Десятилетние тренды и когортное исследование конвенционных факторов риска сердечно-сосудистых заболеваний в городской сибирской популяции: (по материалам проекта ВОЗ MONICA): Автореф. дис…. д-ра мед. наук. Новосибирск; 2001. Cсылка активна на 21.09.2015. Доступно по: https://vivaldi.nlr.ru/bd000155366/view

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies